Apoptosis in Huntington's disease

Miriam A Hickey1, Marie Françoise Chesselet

  • 1Department of Neurology, Reed Neurological Research Center, B114, The David Geffen School of Medicine at UCLA, 710 Westwood Plaza, 90095, Los Angeles, CA, USA.

Insights

Huntington's disease (HD) involves neuronal loss due to a mutant huntingtin gene. While apoptosis is implicated, the exact cell death mechanisms, particularly the role of proapoptotic proteins, are still being investigated for HD pathogenesis.

Area of Science:

  • Neuroscience
  • Genetics
  • Cell Biology

Background:

  • Huntington's disease (HD) is a fatal autosomal dominant disorder characterized by progressive motor, psychiatric, and cognitive decline.
  • The primary pathology involves selective degeneration of striatal medium spiny GABAergic neurons, with up to 95% loss in late stages.
  • The disease is caused by an expanded polyglutamine tract in the huntingtin gene, but the precise mechanism of selective neuronal death remains unclear.

Purpose of the Study:

  • To review the evidence supporting the role of apoptotic pathways and processes in the pathogenesis of Huntington's disease.
  • To explore how mutant huntingtin and proapoptotic proteins contribute to selective neuronal cell death in HD.
  • To discuss the potential significance of apoptosis-related processes over apoptosis itself in HD.

Main Methods:

  • Review of existing scientific literature and in vitro studies.
  • Analysis of evidence linking apoptotic pathways to mutant huntingtin.
  • Examination of theories on proapoptotic protein upregulation and huntingtin cleavage.

Main Results:

  • While direct evidence of apoptosis in HD is scarce, in vitro studies suggest a connection between mutant huntingtin and apoptotic pathways.
  • Upregulation of proapoptotic proteins may lead to huntingtin cleavage, generating toxic fragments that disrupt transcription.
  • Increased proapoptotic proteins might contribute to the slow, selective neuronal death observed in HD.

Conclusions:

  • Apoptosis-related processes, rather than apoptosis per se, are likely key contributors to Huntington's disease pathogenesis.
  • The interplay between mutant huntingtin, proapoptotic proteins, and transcriptional disruption offers a plausible mechanism for selective neurodegeneration in HD.
  • Further research into these apoptotic mechanisms is crucial for understanding and potentially treating Huntington's disease.

Related Concept Videos

Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...